+ Main Category
+ Tell a Friend
Fill out the information below to email a friend a brief note about 'Pomology: Fruit Cultivation and Production'
+ Top 10
+ Directory Statistics
Links: 1182
Categories: 54
Registered Users: 178
Mailing List Subscribers: 24
+ Pagerank Statistics
+ Join Mailing List
Joining mailing list will entitle you to receive occasional emails informing you of news and updates to the site and any special offers that may be of interest to you.
Research > Chapter 9058
Bookmarks
IL-1 mRNA expression detected in-situ hybridization polymerase chain response human thymus thymoma - Correlation late T-cell maturation normal neoplastic thymus.
IL-1 modifies scheme transport activity human rheumatoid synovial cells.
IL-1 modulation cytokine receptors bone marrow cells - vitro vivo investigations.
IL-1 polymorphism patients Korea.
IL-1 receptor accessory protein ST2 comprise IL-33 receptor complex.
IL-1 receptor accessory protein essential IL-33-induced activation T lymphocytes mast cells.
IL-1 receptor TCR signals synergize activate NF-kappa-B-mediated gene transcription.
IL-1 receptor antagonist (IL-1RA) gene polymorphism Sjogren's syndrome rheumatoid arthritis.
IL-1 receptor antagonist (IL-1Ra) dose inhibit production C-reactive protein serum amyloid A protein human primary hepatocytes - Differential regulation normal tumour cells.
IL-1 receptor antagonist (IL-1Ra) plasma levels co-ordinately regulated IL-1Ra Il-1beta genes.
IL-1 receptor antagonist (IL-1ra) expression, function, cytokine-mediated regulation mycobacterial schistosomal antigen-elicited granuloma structure.
IL-1 receptor antagonist affects plasma protein answer Hep 3B cells conditioned medium lipopolysaccharide-stimulated monocytes.
IL-1 receptor antagonist IL-1b production human monocytes regulated differently.
IL-1 receptor antagonist attenuates MAP kinase/AP-1 activation MMP1 expression UVA-irradiated human fibroblasts stimulated culture medium UVB-irradiated human skin keratinocytes.
IL-1 receptor antagonist attenuates sepsis-induced alterations IGF scheme protein synthesis.
IL-1 receptor antagonist gene polymorphism patients secondary acute myeloid leukaemia.
IL-1 receptor antagonist gene polymorphism recurrent spontaneous abortion.
IL-1 receptor antagonist metabolic diseases - Dr Jekyll Mr Hyde?
IL-1 receptor antagonist saliva; characterization normal saliva reduced concentration Sjogren's syndrome (SS).
IL-1 receptor antagonist inhibits recurrence disease syngeneic pancreatic islet transplantation spontaneously diabetic non-obese diabetic (NOD) mice.
IL-1 receptor antagonist prevents apoptosis caspase-3 activation spinal cord injury.
IL-1 receptor antagonist protein production gene expression rheumatoid arthritis osteoarthritis synovium.
IL-1 receptor antagonist regulation acute phase protein synthesis human hepatoma cells.
IL-1 receptor antagonist release regulated differently human alveolar macrophages monocytes.
IL-1 receptor type I expression breast cancer.
IL-1 receptor type I gene expression amygdala inflammatory vulnerable Lewis inflammatory tolerant Fischer rats.
IL-1 receptor-associated kinase 1 mediates protection Staphylococcus aureus infection.
IL-1 receptor-mediated signal essential constituent MyD88-dependent innate answer Mycobacterium tuberculosis infection.
IL-1 receptor-type expression relationship atopy.
IL-1 regulates vivo C-X-C chemokine induction neutrophil sequestration endotoxemia.
IL-1 regulation transin/stromelysin transcription rheumatoid synovial fibroblasts appears involve antagonistic transduction pathways, inhibitory, prostaglandin-dependent pathway mediated cAMP, stimulatory, protein kinase C-dependent pathway.
IL-1 rescues scleroderma myofibroblasts serum-starvation-induced cell death.
IL-1 secretion macrophages. Enhancement IL-1 secretion processing calcium ionophores.
IL-1 serves secondary signal IL-9 expression.
IL-1 signal transduction pathways. Two functional IL-1 receptors expressed T cells.
IL-1 stimulates diverging signaling pathway EL4 6.1 thymoma cells. IL-2 release, IL-2 receptor expression, sensitive pertussis toxin.
IL-1 stimulates ceramide accumulation inducing apoptosis intestinal epithelial cells.
IL-1 stimulates intestinal myofibroblast COX gene expression augments activation Cl- secretion T84 cells.
IL-1 cure inhibits parasitemia protects progress cerebral hemorrhages P. berghei infested mice.
IL-1 type I receptor mediates acute phase answer turpentine, lipopolysaccharide, mice.
IL-1 type I receptor plays key function mediating recruitment leukocytes the nervous scheme.
IL-1, EGF, HGF suppress antiviral activity interferon primary monkey hepatic parenchymal cells.
IL-1, ICAM-1, LFA-3, hydrocortisone differentially regulate cytokine secretion human fetal thymic epithelial cells.
IL-1, IL-4 production IgE levels acute chronic fasciolosis triclabendazole cure.
IL-1, IL-4, IFN-c differentially regulate cytokine production cell surface molecule expression cultured human thymic epithelial cells.
IL-1, IL-6, PDGF mRNA expression alveolar cells stimulation tobacco-derived antigen.
IL-1, TNF-alpha IL-2 production peritoneal spleen cells Schistosoma mansoni infested mice potentiation preimmunization schistosomal antigens immunostimulants.
IL-1- TNF-induced bone resorption mediated p38 mitogen activated protein kinase.
IL-1-alpha IL-6 production oral skin keratinocytes - Similarities differences answer cytokine cure vitro.
IL-1-alpha TNF-alpha act synergistically induce production myeloid colony-stimulating factors cultured human bone marrow stromal cells cloned stromal cell strains.
IL-1-alpha TNF-alpha differentially regulate CD4 Mac-1 expression mouse microglia.
IL-1-alpha gene expression protein production fibroblasts patients systemic sclerosis.
IL-1-alpha gene-transfected human melanoma cells increase tumor-cell adhesion endothelial cells retention lung nude mice.
IL-1-alpha induced, TNF-alpha mediated HLA class II (DR) antigen up-regulation human ductal breast carcinoma cell line ZR-75-1.
IL-1-alpha induces inducible nitric oxide synthase uterine smooth muscle.
IL-1-alpha inhibits human hair follicle growth hair fiber production whole-organ cultures.
IL-1-alpha constitutively expressed rat intestinal epithelial cell line IEC-6.
IL-1-alpha, IL-6 TNF-alpha cutaneous lesions lupus erythematosus inhibited topical function calcipotriol.
IL-1-beta alters beta-adrenergic receptor adenylyl cyclase scheme role human airway epithelial cells.
IL-1-beta amplifies bradykinin-induced prostaglandin E-2 production phospholipase D-linked mechanism.
IL-1-beta IL-3-like activity preterm infants.
IL-1-beta IL-6 stimulate hyperplasia hypertrophy cultured guinea swine airway smooth muscle cells.
IL-1-beta IL-6 selectively stimulate transforming growth factor-beta isoforms human articular chondrocytes.
IL-1-beta IL-6 induce production platelet-activating factor (PAF) cultured rabbit synovial cells.
IL-1-beta TGF-beta-1 modulate sulphation grade chondro-disaccharides porcine articular cartilage. capillary electrophoresis study.
IL-1-beta TNF-alpha Modulate DELTA-9-Tetrahydrocannabinol-Induced Catalepsy Mice.
IL-1-beta TNF-alpha, IL-6, stimulate alpha-1-antichymotrypsin expression human astrocytoma cell line U373 MG.
IL-1-beta converting enzyme (ICE) required apoptosis stimulated lymphokine deprivation IL-2 dependent T cell line.
IL-1-beta decreases expression amyloid precursor protein gene human glioma cells.
IL-1-beta neutrophil degranulation lead IL-6, IL-8, nitrite/nitrate release patients cancer.
IL-1-beta enhances neurite regeneration from transected-nerve terminals of adult rat DRG.
IL-1-beta increases laminin B2 chain mRNA levels activates NF-kappa-B rat glomerular epithelial cells.
IL-1-beta induces synthesis phospholipase A-2-activating protein rabbit distal colon.
IL-1-beta induces coexpression nitric oxide synthase cyclooxygenase islets Langerhans - Activation cyclooxygenase nitric oxide.
IL-1-beta induces degradation equine articular cartilage mechanism mediated nitric oxide.
IL-1-beta inhibits ET-1 production ATII cells vitro - Proof involvement cyclooxygenase 2 pathway.
IL-1-beta required IL-12 stimulate production IFN-gamma NK cells. function IL-1-beta T cell-independent mechanism resistance intracellular pathogens.
IL-1-beta mRNA predominant inflammatory cytokine transcript - Correlation inflammatory cell infiltration human gingiva.
IL-1-beta maturation - Proof mature cytokine structure stimulated specifically nigericin.
IL-1-beta potentiates acetylcholine-induced release vasopressin hypothalamus vitro, amygdala.
IL-1-beta primes IL-8-activated human neutrophils elastase release, phospholipase D activity, calcium flux.
IL-1-beta production human polymorphonuclear leucocytes induced anti-neutrophil cytoplasmic autoantibodies - Relevance systemic vasculitis.
IL-1-beta protein human skin lymph discriminate allergic irritant contact dermatitis.
IL-1-beta regulates rat mesangial cyclooxygenase II gene expression tyrosine phosphorylation.
IL-1-beta regulates expression Gi2-alpha gene lipid mediators guinea swine tracheal muscle.
IL-1-beta release cultured bronchial epithelial cells bronchoalveolar lavage cells allergic normal humans segmental challenge ragweed.
IL-1-beta stabilizes COX II mRNA renal mesangial cells - Role 3-untranslated area.
IL-1-beta stimulates superoxide delayed peroxynitrite production pulmonary vascular smooth muscle cells.
IL-1-beta transduces diverse signals IL-1-alpha leading class II antigen expression beta-insulinoma RIN-5AH cells special receptors.
IL-1-beta, TNF-alpha, IL-2 peritoneal fluid macrophage-conditioned media women endometriosis.
IL-1-beta major stimulator hyaluronan synthesis vitro human peritoneal mesothelial cells - Relevance peritonitis CAPD.
IL-1-beta-converting enzyme present monocytic cells inactive 45-kDa precursor.
IL-1-beta-like Freund's adjuvant enhances axonal transport opiate receptors sensory neurons.
IL-1-converting enzyme requires aspartic acid residues processing IL-1b precursor distinct sites cleave 31-kDa IL-1a.
IL-1-induced iNOS expression in human astrocytes via NF-kappa-B.
IL-1-induced nitric oxide inhibits chondrocyte proliferation PGE2.
IL-1-induced prostacyclin production cerebral vascular endothelial cells inhibits myelin basic protein-specific lymphocyte proliferation.
IL-1-induced receptor activator NF-kappa B ligand human periodontal ligament cells involves ERK-dependent PGEproduction.
IL-1-mediated inhibition IL-6-induced STAT3 activation modulated IL-4, MAP kinase inhibitors redox condition HepG2 cells.
IL-1-related cytokine responses nonimmune skin cells subjected CEES exposure potential vesicant antagonists.
IL-1/IL-3 gene therapy non-small cell lung cancer (NSCLC) rats cracked adenoproducer cells.
IL-10 Augments Antibody Production in Vitro Immunized Lymphocytes Inducing Th2-Type Response B Cell Maturation.
IL-10 Controls Ultraviolet-Induced Carcinogenesis Mice.
IL-10 Helps Control Pathogen Load High-Level Bacteremia.
IL-10 Induces IL-10 Primary Human Monocyte-Derived Macrophages Transcription Factor Stat3.
IL-10 Inhibits Cysteinyl Leukotriene-Induced Activation Human Monocytes Monocyte-Derived Dendritic Cells.
IL-10 Inhibits Cytokine Production, Vascular Leakage, Swelling During T Helper 1 Cell-Induced Delayed-Type Hypersensitivity.
IL-10 Prevents naturally occurring fetal loss CBA times DBA/2 mating combination, local defect IL-10 production abortion-prone combination corrected vivo injection IFN-tau.
IL-10 Regulates Movement Intestinally Derived CD4+ T Cells Liver.
IL-10 Suppresses Mast Cell IgE Receptor Expression Signaling In Vitro In Vivo.
IL-10 Synergizes multiple cytokines enhancing HIV production cells monocytic lineage.
IL-10 Underlies Distinct Vulnerability BALB/c C57BL/6 Mice Mycobacterium avium Infection Effects Efficacy Antibiotic Therapy.
IL-10 act antigen-presenting cell inhibit cytokine production Th1 cells.
IL-10 alters DC role modulation cell surface molecules resulting impaired T-cell responses.
IL-10 GM-CSF expression presence antigen-presenting cells chronic venous ulcers.
IL-10 IFN-gamma Guillain-Barre syndrome.
IL-10 IL-3 synergize proliferation human T cells.
IL-10 IL-4 co-operate normalize vitro IgA production IgA-lacking (IgAD) patients.
IL-10 IL-4 regulate type-I type-II IL-1 receptors expression IL-1beta-activated mouse primary astrocytes.
IL-10 IL-4 synergize TNF-alpha stimulate IL-1ra production human neutrophils.
IL-10 IL-6 gene polymorphisms potential host vulnerability factors Brucellosis.
IL-10 Natural Regulatory T Cells - Two Independent Anti-Inflammatory Mechanisms Herpes Simplex Virus-Induced Ocular Immunopathology.
IL-10 TGF-b Control Establishment Persistent Transmissible Infections Produced Leishmania tropica C57BL/6 Mice.
IL-10 TGF-beta cooperate regulatory T cell answer mucosal allergens normal immunity special immunotherapy.
IL-10 TGF-beta differ regulation aminopeptidase N/CD13 expression monocytes.
IL-10 TNF-alpha polymorphisms recovery HCV infection.
IL-10 antibodies TGF-beta2 PDGF inhibit RPE-mediated retinal contraction.
IL-10 sIL-2R serum levels potential peripheral blood prognostic markers passage adenoma colorectal cancer.
IL-10 resolution infections.
IL-10 toll-like receptor-4 polymorphisms vivo vivo answer endotoxin.
IL-10 trichosanthin inhibited surface molecule expression antigen processing cells T-cell proliferation.
IL-10 viral IL-10 prevent IL-4-induced IgE synthesis inhibiting accessory cell role monocytes.
IL-10 mediator HPA axis brain.
IL-10 autocrine regulator CSF secretion monocytes - Disparate effects GM-CSF G-CSF secretion.
IL-10 attenuates IFN-alpha-activated STAT1 liver - Involvement SOCS2 SOCS3.
IL-10 attenuates hepatic I/R injury promotes hepatocyte proliferation.
IL-10 augments CD23 expression U937 cells down-regulates IL-4-driven CD23 expression cultured human blood monocytes - Influences IL-10 cytokines cell phenotype phagocytosis.
IL-10 augments antibody production in vitro immunized lymphocytes inducing Th2-type answer B cell maturation.
IL-10 augments IFN-gamma TNF-alpha stimulated TARC production HaCaT cells. potential mechanism inflammatory response atopic dermatitis.
IL-10 blocks collagen IV invasion invasion stimulating factor activated PC-3 ML cells - Upregulation TIMP-1 expression.
IL-10 stimulate expression EBV-encoded latent membrane protein-1 (LMP-1) absence EBNA-2 B lymphocytes Burkitt lymphoma-and NK lymphoma-derived cell lines.
IL-10 controls ultraviolet-induced carcinogenesis mice.
IL-10 converts mouse lymphoma cells CTL-resistant, NK-sensitive phenotype peptide-inducible MHC class I expression.
IL-10 cooperates TNF-a activate HIV-1 latently acutely infested cells monocyte/macrophage lineage.
IL-10 cooperates TNF-alpha activate HIV-1 latently acutely infested cells monocyte/macrophage lineage.
IL-10 insufficiency inhibit insulitis accelerates cyclophosphamide-induced diabetes nonobese diabetic mouse.
IL-10 insufficiency increases superoxide endothelial dysfunction inflammation.
IL-10 insufficiency leads somatic mutations model IBD.
IL-10 insufficiency prevents IL-5 overproduction eosinophilic inflammation murine model asthma-like response.
IL-10 insufficiency promotes increased Borrelia burgdorferi clearance predominantly enhanced innate immune responses.
IL-10 differentially regulates mRNA expression stimulated lipopolysaccharide interferons murine peritoneal macrophages.
IL-10 acts T cells specifically altering CD28 co-stimulation pathway.
IL-10 affect oxidative burst expression selected surface antigen human blood phagocytes vitro.
IL-10 play function cutaneous Photofrin(R) photodynamic therapy-induced suppression contact hypersensitivity answer.
IL-10 down-regulates T cell activation antigen-resenting liver sinusoidal endothelial cells decreased antigen absorption mannose receptor lowered surface expression accessory molecules.
IL-10 down-regulates costimulatory molecules Mycobacterium tuberculosis-pulsed macrophages impairs lytic activity CD4 CD8 CTL tuberculosis patients.
IL-10 down-regulates human microglial IL-8 by inhibition of NF-kappaB activation.
IL-10 enhances B-cell IgE synthesis promoting differentiation plasma cells process inhibited CD27/CD70 interaction.
IL-10 enhances IL-2-induced proliferation cytotoxicity human intestinal lymphocytes.
IL-10 enhances NK cell proliferation, cytotoxicity production IFN-gamma combined IL-18.
IL-10 enhances expression IL-2 receptor alpha chain T cells.
IL-10 enhances resolution pulmonary inflammation vivo promoting apoptosis neutrophils.
IL-10 enhances growth Legionella pneumophila human mononuclear phagocytes reverses protective influence IFN-c. Differential responses blood monocytes alveolar macrophages.
IL-10 exerts suppressive enhancing effects antifungal activity mononuclear phagocytes Aspergillus fumigatus.
IL-10 expression CT26 colon carcinoma cells inhibits malignant phenotype induces T cell-mediated tumor rejection context systemic Th2 answer.
IL-10 expression thyroid glands - Protective harmful function thyroid autoimmunity?
IL-10 expression expression platelet-derived endothelial cell growth factor prognosis oral oropharyngeal carcinoma.
IL-10 expression profiling human monocytes.
IL-10 fails abrogate experimental autoimmune encephalomyelitis.
IL-10 fails inhibit production IL-18 answer inflammatory stimuli.
IL-10 CD4(+)CD25(-)Foxp3(-)CD127(-) adaptive regulatory T cells modulates parasite clearance pathology malaria infection.
IL-10 gene expression marker detection protective immunity levels irradiated cercarial vaccine experimental Schistosoma mansoni infection.
IL-10 gene knockout attenuates allergen-induced airway hyperresponsiveness C57BL/6 mice.
IL-10 gene modification immature dendritic cells induces antigen-specific tolerance experimental autoimmune myocarditis.
IL-10 gene modified dendritic cells stimulated antigen-specific tolerance experimental autoimmune myocarditis.
IL-10 gene modified dendritic cells inhibit T helper type 1-mediated alloimmune responses promote immunological tolerance diabetes.
IL-10 gene polymorphism herpesvirus infections.
IL-10 gene polymorphisms infectious sudden infant death.
IL-10 gene polymorphisms infectious disease SIDS.
IL-10 gene therapy prevents TNBS-induced colitis.
IL-10 gene transfer attenuates P. gingivalis-induced inflammation.
IL-10 gene transfer intracranial 9L glioma - Tumor inhibition cooperation IL-2.
IL-10 genotype examination patients Behcet's disease.
IL-10 genotype predicts serum levels adhesion molecules, inflammation atherosclerosis hemodialysis patients.
IL-10 haplotypes potential predictors spontaneous clearance HCV infection.
IL-10 distinct immunoregulatory influence naive active T cell subsets.
IL-10 improves lung injury survival Pseudomonas aeruginosa pneumonia.
IL-10 HIV infection - Increasing serum IL-10 levels disease progression-down-regulatory influence potent anti-retroviral therapy.
IL-10 antilipopolysaccharide immunity systemic Klebsiella infections.
IL-10 vivo gene expression cell-induced animal model proliferative vitreoretinopathy.
IL-10 increases number CFU-GM generated vivo expansion unmanipulated human MNCs selected CD34+ cells.
IL-10 induces DNA binding activity STAT proteins (Stat1, Stat3, Stat5) distinct combinatorial assembly promoters selected genes.
IL-10 induces IL-10 primary human monocyte-derived macrophages transcription factor Stat3.
IL-10 induces Th2 cell tolerance allergic asthma.
IL-10 induces apoptosis human monocytes involving CD95 receptor/ligand pathway.
IL-10 induces gene expression macrophages - Partial overlap IL-5 IL-4 stimulated genes.
IL-10 induces mesangial cell proliferation PDGF-dependent mechanism.
IL-10 induces tyrosine phosphorylation tyk2 Jak1 differential assembly STAT1-alpha STAT3 complexes human T cells monocytes.
IL-10 induces tyrosine phosphorylation tyk2 Jak1 differential assembly STAT1a STAT3 complexes human T cells monocytes.
IL-10 induces transcription gene mouse mast cell protease-1 serine protease preferentially expressed mucosal mast cells Trichinella spiralis-infected mice.
IL-10 inhibition human prostate PC-3 ML cell metastases SCID mice - IL-10 stimulation TIMP-1 inhibition MMP-2/MMP-9 expression.
IL-10 inhibits CD28 ICOS costimulations T cells src homology 2 domain-containing protein tyrosine phosphatase 1.
IL-10 inhibits HIV-1 replication stimulated Tat.
IL-10 inhibits IL-7-mediated murine pre-B cell growth vitro.
IL-10 inhibits LPS-induced human monocyte tissue factor expression blood.
IL-10 inhibits Porphyromonas gingivalis LPS-stimulated human gingival fibroblasts production IL-6.
IL-10 inhibits T cell-independent T cell-dependent responses vitro.
IL-10 inhibits alloreactive cytotoxic T lymphocyte generation vivo.
IL-10 inhibits apoptotic cell death human T cells starved IL-2.
IL-10 inhibits cytokine production activated macrophages.
IL-10 inhibits cytokine production, vascular leakage, swelling T helper 1 cell-induced delayed-type hypersensitivity.
IL-10 inhibits endothelium-dependent T cell costimulation up-regulation ILT3/4 human vascular endothelial cells.
IL-10 inhibits human T cell proliferation IL-2 production.
IL-10 inhibits inflammation affect fibrosis pulmonary answer bleomycin.
IL-10 inhibits lipopolysaccharide-induced CD40 gene expression induction suppressor cytokine signaling-3.
IL-10 inhibits lipopolysaccharide-induced murine B cell proliferation cross-linking surface antigen receptors ligation CD40 restores answer.
IL-10 inhibits macrophage costimulatory activity selectively inhibiting up-regulation B7 expression.
IL-10 inhibits mitogen-induced T cell proliferation selectively inhibiting macrophage costimulatory role.
IL-10 inhibits nitric oxide synthesis murine uterus.
IL-10 inhibits nuclear factor-kB/Rel nuclear activity CD3-stimulated human peripheral T lymphocytes.
IL-10 inhibits nuclear factor-kappa-B/Rel nuclear activity CD3-stimulated human peripheral T lymphocytes.
IL-10 inhibits parasite killing nitrogen oxide production IFN- gamma -activated macrophages.
IL-10 inhibits parasite killing nitrogen oxide production IFN-c-activated macrophages.
IL-10 inhibits prostaglandin E-2 production lipopolysaccharide-stimulated monocytes.
IL-10 inhibits adhesion leukocytic cells IL-1-activated human endothelial cells.
IL-10 inhibits synthesis migration inhibitory factor migration inhibitory factor-mediated macrophage activation.
IL-10 inhibits transcription cytokine genes human peripheral blood mononuclear cells.
IL-10 inhibits tumor antigen presentation epidermal antigen-presenting cells.
IL-10 inhibits vascular smooth muscle cell activation vitro vivo.
IL-10 interrupts memory B cell expansion germinal center inducing differentiation plasma cells.
IL-10 autocrine inhibitor human placental cytotrophoblast MMP-9 production invasion.
IL-10 essential disease protection intranasal peptide administration C57BL/6 model EAE.
IL-10 excluded functional cytokine memory human CD4(+) memory T lymphocytes.
IL-10 highly expressed cryptorchid cryptepididymal epithelium. probable mechanism preventing immune responses autoantigenic spermatozoa epididymal tubule.
IL-10 stimulated HIV-1 infection capable decreasing viral replication human macrophages.
IL-10 involved protective influence dibutyryl cyclic adenosine monophosphate endotoxin-induced inflammatory liver injury.
IL-10 FasL-induced protection experimental autoimmune thyroiditis FasL-induced immune deviation.
IL-10 protective intestinal ischemia reperfusion injury.
IL-10 produced subsets human CD4+ T cell clones peripheral blood T cells.
IL-10 required optimal CD8 T cell memory Listeria monocytogenes infection.
IL-10 required prevent immune hyperactivity infection Trypanosoma cruzi.
IL-10 regulated early transitional stages vervet monkeys artificially infested Trypanosoma brueei rhodesiense.
IL-10 levels decreased psoriatic lesional skin compared psoriatic lesion-free normal skin suction blister fluids.
IL-10 levels Dengue patients - Some findings exceptional epidemiological conditions Cuba.
IL-10 levels cerebrospinal fluid serum patients severe traumatic brain injury - Relationship IL-6, TNF-alpha, TGF-beta1 blood-brain barrier role.
IL-10 determination aqueous humor screening patients suspicion primary intraocular lymphoma.
IL-10 mediates immunosuppression primary infection Toxoplasma gondii mice.
IL-10 mediates vulnerability Trypanosoma cruzi infection.
IL-10 mediation activation-induced Th1 cell apoptosis lymphoid dysfunction polymicrobial sepsis.
IL-10 modulates cytokine gene transciption protein synthesis-independent dependent mechanisms lipopolysaccharide-treated neutrophils.
IL-10 modulates structure osteoclasts murine hemopoietic cultures.
IL-10 modulates intestinal damage epithelial cell apoptosis T cell-mediated enteropathy.
IL-10 neutralization augments mouse resistance systemic Mycobacterium avium infections.
IL-10 overexpression decreases inflammatory mediators promotes regenerative healing adult model scar structure.
IL-10 permits transient activation dendritic cells tolerize T cells protect from nervous scheme autoimmune disease.
IL-10 plasma levels elevated LPS injection splenectomized A/J mice.
IL-10 plays function modulation human granulomatous hypersensitivity Schistosoma mansoni eggs stimulated immune complexes.
IL-10 polymorphism cell-mediated immune answer Chlamydia trachomatis.
IL-10 polymorphism increased occurrence severe sepsis.
IL-10 polymorphisms early-onset celiac disease severe mucosal damage patients Caucasian origin.
IL-10 prevents naturally occurring fetal loss CBA DBA/2 mating combination, local defect IL-10 production abortion-prone combination corrected vivo injection IFN- tau.
IL-10 prevents naturally occurring fetal loss CBA DBA/2 mating combination, local defect IL-10 production abortion-prone combination corrected vivo injection IFN-t.
IL-10 prevents differentiation monocytes dendritic cells promotes maturation macrophages.
IL-10 producing CD14low monocytes inhibit lymphocyte-dependent activation intestinal epithelial cells commensal bacterian.
IL-10 producing CD8(+) T cells human infection Leishmania guyanensis.
IL-10 production CD40L expression patients usual variable immunoinsufficiency.
IL-10 production adult human derived microglial cells.
IL-10 production B cells confined CD154+ cells patients systemic lupus erythematosus.
IL-10 production circulating T cells differs allergen-induced extracted early dual asthmatic responders.
IL-10 production usual variable immunoinsufficiency.
IL-10 production cutaneous basal squamous cell carcinomas - mechanism evading local T cell immune answer.
IL-10 production cutaneous basal squamous cell carcinomas. mechanism evading local T cell immune answer.
IL-10 production mouse hepatocytes augmented TGF-beta.
IL-10 production stimulated HIV-1 Tat stimulation human monocytes dependent activation PKC betaII delta isozymes.
IL-10 production enhanced human T cells IL-12 IL-6 monocytes tumor necrosis factor-a.
IL-10 production enhanced human T cells IL-12 IL-6 monocytes tumor necrosis factor-alpha.
IL-10 promoter IL4-R alpha gene SNPs beta-lactam allergy atopic women.
IL-10 promoter gene polymorphism incidence chronic GVHD medical systemic immunosuppressive cure chronic GVHD allogeneic peripheral blood stem cell transplantation.
IL-10 promoter haplotype effect interferon cure answer multiple sclerosis.
IL-10 promoter nt -1082A/G polymorphism human papillomavirus infection cytologic abnormalities uterine cervix.
IL-10 promoter polymorphisms effect disease severity psoriasis.
IL-10 promoter-1082 polymorphism elevated IL-10 levels control subjects explain elevated plasma IL-10 observed Sjogren's syndrome Hungarian cohort.
IL-10 promotes survival microglia activating Akt.
IL-10 protects mouse intestinal epithelial cells Fas-induced apoptosis modulating Fas expression altering caspase-8 FLIP expression.
IL-10 receptor coreceptor expression quiescent activated hepatic stellate cells.
IL-10 receptor dysfunction macrophages chronic inflammation.
IL-10 reduces Th2 cytokine production eosinophilia augments airway reactivity allergic mice.
IL-10 reduces rat brain injury focal stroke.
IL-10 regulates movement intestinally derived CD4(+) T cells liver.
IL-10 regulation HIV-Tat primary human monocytic cells - Involvement calmodulin/calmodulin-dependent protein kinase-activated p38 MAPK Sp-1 CREB-1 transcription factors.
IL-10 regulation lupus NZM2410 murine model.
IL-10 selectively regulates murine Ig isotype switching.
IL-10 signaling essential 1,25-dihydroxyvitamin D-3-mediated inhibition experimental autoimmune encephalomyelitis.
IL-10 signaling IL-10E1 dependent tyrosine phosphorylation IL-10R alpha chain human primary prostate cancer cell lines.
IL-10 stimulates monocyte FccR surface expression cytotoxic activity. Distinct regulation antibody-dependent cellular cytotoxicity IFN-c, IL-4, IL-10.
IL-10 stimulates monocytes Fc-gamma-R surface expression cytotoxic activity - Distinct regulation antibody-dependent cellular cytotoxicity IFN-gamma,IL-4, IL-10.
IL-10 stimulates murine antigen-driven antibody responses vitro regulating helper cell subset participation.
IL-10 stimulatory effects human NK cells explored gene profile examination.
IL-10 subfamily members - IL-19, IL-20, IL-22, IL-24 IL-26.
IL-10 suppresses LPS-induced KC mRNA expression translation-dependent decrease mRNA stability.
IL-10 suppresses experimental autoimmune neuritis down-regulates T-H1-type immune responses.
IL-10 suppresses mast cell IgE receptor expression signaling vitro vivo.
IL-10 suppressor activity vivo Tr1 cell role impaired multiple sclerosis.
IL-10 synergistically enhances GM-CSF-induced CCR1 expression myelomonocytic cells.
IL-10 synergizes IL-4 transforming growth factor- beta inhibit macrophage cytotoxic activity.
IL-10 synergizes IL-4 transforming growth factor-b inhibit macrophage cytotoxic activity.
IL-10 cure macrophages bolsters intracellular survival Mycobacterium leprae.
IL-10 underlies distinct vulnerability BALB/c C57BL/6 mice Mycobacterium avium infection influences efficacy antibiotic therapy.
IL-10 up-regulates human monocyte phagocytosis presence IL-4 IFN-gamma.
IL-10 up-regulates nitric oxide (NO) synthesis lipopolysaccharide (LPS)-activated macrophages - Improved control Trypanosoma cruzi infection.
IL-10, IFN- gamma TNF- alpha acute chronic human fascioliasis.
IL-10, IFN-gamma TNF-alpha acute chronic human fascioliasis.
IL-10, IL-6 CD14 polymorphisms sepsis outcome ventilated birth volume infants.
IL-10, IL-6, TNF-alpha: factors altered cytokine network uremia: The good, bad, ugly.
IL-10, T lymphocyte inhibitor human blood cell production IL-1 tumor necrosis factor.
IL-10 growth cofactor mature immature T cells.
IL-10, inflammatory/inhibitory cytokine,.
IL-10, regulatory T cells, Kupffer cells mediate tolerance concanavalin A-induced liver injury mice.
IL-10- IL-12-independent down-regulation allergic sensitization stimulation CD40 signaling.
IL-10- TGF- beta -mediated vulnerability kala-azar post-kala-azar dermal leishmaniasis - significance amphotericin B control Leishmania donovani infection India.
IL-10- TGF-b-Mediated Vulnerability Kala-azar Post-kala-azar Dermal Leishmaniasis - The Significance Amphotericin B Control Leishmania donovani Infection India.
IL-10- TGF-beta-mediated vulnerability kala-azar post-kala-azar dermal leishmaniasis - The significance amphotericin B control Leishmania donovani infection India.
IL-10-insufficiency unmasks unique immune scheme defects reveals differential regulation organ-specific autoimmunity non-obese diabetic mice.
IL-10-dependent down-regulation MHC class II expression degree monocytes peritoneal fluid endometriosis patients.
IL-10-dependent partial refractoriness Toll-like receptor stimulation modulates gut mucosal dendritic cell role.
IL-10-driven immunoglobulin production B lymphocytes IgA-lacking individuals correlates infection proneness.
IL-10-induced factors belonging p91 family proteins bind IFN-c-responsive promoter elements.
IL-10-mediated suppression TNF-alpha production independent ability inhibit NFkappaB activity.
IL-10-producing macrophages preferentially clear early apoptotic cells.
IL-10-producing monocytes differentiate alternatively activated macrophages increased atopic patients.
IL-10-transduced bone marrow mesenchymal stem cells attenuate severity acute graft-versus-host disease experimental allogeneic stem cell transplantation.
IL-10-treated dendritic cells decrease airway hyperresponsiveness airway inflammation mice.
IL-10/Fc inhibits macrophage role prolongs pancreatic islet xenograft survival.
IL-10. counter-balancing immunologic factor visceral leishmaniasis.
IL-10 - The Master Regulator Immunity infection.
IL-10. cytotoxic T cell differentiation factor.
IL-11 stimulates murine human erythroid burst structure semisolid cultures.
IL-11 enhances survival decreases TNF production radiation-induced thoracic injury.
IL-11 expression increased severe asthma - Association epithelial cells eosinophils.
IL-11 combination SLF G-CSF GM-CSF significantly increases expansion extracted CD34+ cell population cord blood vs. adult bone marrow.
IL-11 inhibits Clostridium difficile toxin A enterotoxicity rat ileum.
IL-11 pretreatment reduces cell death intestinal ischemia-reperfusion.
IL-11 regulates macrophage effector role inhibition nuclear factor-kB.
IL-11 synergizes IL-3 promoting recovery immune scheme irradiation.
IL-11-induced reduction C/EBP transcription factor binding contribute IL-12 downregulation tumor-bearing mice.
IL-11 - Insights asthma overexpression transgenic modeling.
IL-12 Controls Cytotoxicity New Subset Self-Antigen-Specific Human CD28+ Cytolytic T Cells.
IL-12 ELISPOT assays detect enumerate IL-12 secreting cells.
IL-12 Increases Resistance BALB/c Mice Mycobacterium tuberculosis Infection.
IL-12 Induction mRNA Encoding Substance P Murine Macrophages Spleen Sites Inflammation.
IL-12 Inhibits Apoptosis Induced Human Th1 Clone gp120/CD4 Cross-Linking CD3/TCR Activation IL-2 Deprivation.
IL-12 Is Required Anti-OX40-Mediated CD4 T Cell Survival.
IL-12 Knockout C57BL/6 Mice Protected Re-infection Cryptosporidium parvum Challenge.
IL-12 Modulation T helper responses filarial helminth, Brugia malayi.
IL-12 Protects Bone Marrow Sensitizes Intestinal Tract Ionizing Radiation.
IL-12 Regulation parasite antigen-drive IgE production human helminth infections.
IL-12 Signaling Drives CD8+ T Cell IFN-g Production Differentiation KLRGI+ Influenceor Subpopulations Toxoplasma gondii Infection.
IL-12 Stimulates Antiviral Type 1 Cytokine Response Lacks Adjuvant Activity IFN-gamma-Receptor-Deficient Mice.
IL-12 Stimulates Progress Acute Graft-Versus-Host Disease Mice That Normally Would Develop Chronic, Autoimmune Graft-Versus-Host Disease.
IL-12 Synergizes IL-2 stimulate lymphokine-activated cytotoxicity perforin granzyme gene expression fresh human NK cells.
IL-12 abrogates immune privilege anterior chamber eye.
IL-12 activates IFN-c production preferential activation CD30+ T cells.
IL-12 activates IFN-gamma production preferential activation CD30+ T cells.
IL-12 acts DC promote nuclear localization NF-kappaB primes DC IL-12 production.
IL-12 administered vivo young mice. Discrepancy effects tumor growth vivo cytotoxic T lymphocyte generation vivo - Dependence IFN-gamma.
IL-12 affects Dermatophagoides farinae-induced IL-4 production T cells pediatric patients mite-sensitive asthma.
IL-12 IFN-gamma production, NK cell activity, acute chronic experimental Trypanosoma cruzi infections.
IL-12 IL-10 polymorphisms effects cytokine production.
IL-12 IL-15 stimulate activation nuclear PLCbeta human natural killer cells.
IL-12 IL-18 stimulate MAP kinase-dependent adhesion T cells extracellular matrix components.
IL-12 IL-18 synergistically stimulate bactericidal activity murine peritoneal cells M. leprae.
IL-12 Type-I IFN Synergize IFN-g Production CD4 T Cells, Whereas Neither Are Required IFN-g Production CD8 T Cells Listeria monocytogenes Infection.